Alcoholism

NRSInsights’ March 2024 Retail Same-Store Sales Report

Retrieved on: 
Monday, April 8, 2024
DMA's, Cooking, POS, National Retail Solutions, SVP, Sale, Tobacco, Foodservice, Commerce, Energy drink, NRS, Alcoholism, Calendar, Cryptocurrency

NEWARK, N.J., April 08, 2024 (GLOBE NEWSWIRE) -- NRSInsights, a provider of sales data and analytics drawn from retail transactions processed through the National Retail Solutions (NRS) point-of-sale (POS) platform, today announced comparative same-store sales results for March 2024.

Key Points: 
  • March same-store sales jumped 7.2% year-over-year, the highest rate of increase since June 2023
    NEWARK, N.J., April 08, 2024 (GLOBE NEWSWIRE) -- NRSInsights , a provider of sales data and analytics drawn from retail transactions processed through the National Retail Solutions (NRS) point-of-sale (POS) platform, today announced comparative same-store sales results for March 2024.
  • (Same-store sales, unit sales, transactions, and average price data throughout this release refer to March 2024 unless otherwise noted.
  • Same-store sales per calendar day in February 2024 had increased 7.4% compared to January 2024.
  • The NRSInsights monthly Same-Store Retail Sales Reports are intended to provide timely topline data reflective of sales at NRS’ network of independent, predominantly urban, retail stores.

RC Show 2024 Unveils Exciting Bar and Beverage Lineup to Help LEVEL UP Industry Standards

Retrieved on: 
Monday, March 25, 2024
Madri, Veira, Master class, Michelin, Elevation, Biting, Whisky, Molson Brewery, LEVEL, Data, Latte art, History, Human, Food, RC, Enercare Centre, Thought, Taste, SSC, Energy drink, System, Creativity, Alcoholism, Rail, Beer, Rice water

For more information on this year’s event, visit www.rcshow.com.Get your questions answered and follow the conversation on social at #RCShow @RestaurantsCanada-- 30 --Media Contacts:Lisa Raffaele │ 647.896.0743 │ [email protected] Katherine Doak│ 647.465.4605 │[email protected] About RC Show – since 1944

Key Points: 
  • Speakers and panelists include:
    Andre Hueston Mack, bar keynote speaker, recently proclaimed 'one of wine's most inspiring people', is a true wine Renaissance Man.
  • From changes in decor to tweaks in your bar program, if you're thinking about expansion, this panel is for you.
  • RC Show Bar & Beverage Ambassadors Christina Veira and Evelyn Chick, are curating sessions and workshops that touch on the state of Canada’s bar and beverage scene.
  • They will be presenting their distinctive methods for crafting menus and blending flavours to create delicious cocktails and mocktails.

Breakthrough in Wellness: Clearmind Medicine's Psychedelic Treatment Granted Divisional Patent Approval in China

Retrieved on: 
Tuesday, March 19, 2024
Alcoholism, CWY, Binge drinking, MEAI, IP, Patent, Therapy, Pharmaceutical industry

Tel Aviv, Israel / Vancouver, Canada, March 19, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY) (“Clearmind” or the "company"), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, announced that it has been granted divisional patent approval by the China National Intellectual Property Administration.

Key Points: 
  • The divisional patent approval, previously announced, grants Clearmind a broader claim than patent application.
  • This latest patent builds upon Clearmind’s broad IP protection in the psychedelic space, which now includes 27 granted patents and 24 pending patent applications across 15 patent families, nine of which have been granted in major jurisdictions such as the US, Europe, China, and India.
  • The granting of this latest patent establishes both the company's patent protection around its flagship molecule as well as its extensive IP protection in the psychedelic space.
  • Clearmind’s MEAI may also be used to treat binge drinking, which can be a deadly addiction for some.

Clearmind Medicine Obtains Clearance for its Psychedelic- Based Alcoholism Clinical Trial

Retrieved on: 
Wednesday, March 13, 2024
Dopamine, NET, Reward, Sheba Medical Center, CWY, Psychiatry, Serotonin, Patient, Research, MEAI, Alcoholism, Clinical trial, DAT, Safety, Norepinephrine, Yale school, Therapy, Ministry, Pharmaceutical industry

The approval, previously announced on February 23, 2024, allows Clearmind to start its pioneering clinical trial.

Key Points: 
  • The approval, previously announced on February 23, 2024, allows Clearmind to start its pioneering clinical trial.
  • The clinical trial is a multinational, multi-center, single and multiple dose tolerability, safety and pharmacokinetic study of CMND-100 in healthy volunteers and AUD subjects.
  • The Clearmind team has been working tirelessly on the research and development of a novel treatment to the global epidemic of alcoholism.
  • We are eager to continue our work with patients in need of help,” said Dr. Adi Zuloff-Shani, CEO of Clearmind Medicine.

United States Alternative Adult Beverages Market Report Explores Emerging Adult Beverage Sectors and Innovative Brands - ResearchAndMarkets.com

Retrieved on: 
Monday, April 1, 2024
Retail, Wine & Spirits, HARD, RTD, Drink, Growth, White Claw Hard Seltzer, Coronavirus, Research, Collision, CBD, Wine, Hard seltzer, Alcoholism, Maharajkumar of Vizianagram, THC, Hard, Liquor

The "2023 Alternative Adult Beverages in the U.S." report from Beverage Marketing has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "2023 Alternative Adult Beverages in the U.S." report from Beverage Marketing has been added to ResearchAndMarkets.com's offering.
  • The Alternative Adult Beverages in the U.S. report examines the burgeoning adult beverage types expanding the adult beverage horizon beyond the standard beer, wine and distilled spirits categories.
  • This market report includes data as well as discussion of innovation and the consumer need states and attitudes driving it.
  • The report discusses a broad range of entrepreneurial brands in various emerging sectors and sub-sectors and quantifies key sectors and brands.

United States Energy Drink Market Forecast to Reach a Valuation of US$ 33.0 Billion by 2030 - ResearchAndMarkets.com

Retrieved on: 
Friday, March 22, 2024
Food, Beverage, Retail, Pesticide, Glass, Convenience, Energy drink, Woman, Social media, Female, Metal, Nature, Drink, Women and Men, Adolescence, Marketing, Alcoholism

The "United States Energy Drink Market, Size, Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "United States Energy Drink Market, Size, Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis" report has been added to ResearchAndMarkets.com's offering.
  • The United States energy drink industry is witnessing dynamic changes with a projected market growth at a CAGR of 8.01% from 2024 to 2030.
  • Growth in the energy drink market is driven by a variety of factors, including the rising demand for beverages that enhance physical and cognitive performance.
  • Increased focus on developing energy drink variants that resonate with health trends, including hemp-based and caffeinated natural alternatives.

The Truth About Babe Ruth

Retrieved on: 
Monday, April 1, 2024
Waite Hoyt, Cincinnati Reds, University, Student, Human, Insurance, Woman, Radio, World Series, Babe Ruth, Alcoholism, University of Nebraska Press, Dressmaker

LINCOLN, Neb., April 1, 2024 /PRNewswire/ -- Today is a major milestone for Yankees ace pitcher and Babe Ruth buddy Waite Hoyt – even though Hoyt's been dead for almost 40 years. His memoir, "Schoolboy: The Untold Journey of a Yankees Hero" (University of Nebraska Press) arrives in bookstores nationwide and on Amazon.

Key Points: 
  • LINCOLN, Neb., April 1, 2024 /PRNewswire/ -- Today is a major milestone for Yankees ace pitcher and Babe Ruth buddy Waite Hoyt – even though Hoyt's been dead for almost 40 years.
  • Often remembered as "Babe Ruth's best friend," Hoyt was a staunch keeper of the Great Bambino's flame.
  • "Babe Ruth was so misunderstood and misrepresented by so many," Hoyt wrote.
  • Hoyt continued: "I saw Babe naked many times, and his chest was as thick as his stomach.

Late Yankees Ace Publishes New Memoir

Retrieved on: 
Monday, March 18, 2024
Waite Hoyt, Amazon, Yankee, Cincinnati Reds, University, Student, Human, Radio, World Series, Bomb, Alcoholism, University of Nebraska Press, Tissue paper

LINCOLN, Neb., March 18, 2024 /PRNewswire/ -- The first of April, 2024, will be a big day for a late, great man. Waite Hoyt of the 1927 New York Yankees will release a new book: "Schoolboy: The Untold Journey of a Yankees Hero." (University of Nebraska Press) His memoir!

Key Points: 
  • LINCOLN, Neb., March 18, 2024 /PRNewswire/ -- The first of April, 2024, will be a big day for a late, great man.
  • Waite Hoyt of the 1927 New York Yankees will release a new book: "Schoolboy: The Untold Journey of a Yankees Hero."
  • Waite Hoyt was not only the ace pitcher of the 1920s Yankees, but he was also an incredible storyteller who left behind eight boxes of notes, writings, interview transcripts and memoir attempts.
  • Waite Hoyt (1899-1984) pitched twenty-one Major League seasons and led the Yankees to three World Series championships.

Clearmind Medicine Receives Approval to Commence its Phase I/IIa Clinical Trial of CMND-100 for Alcohol Use Disorder

Retrieved on: 
Friday, February 23, 2024
Therapy, Reward, Alcoholism, Ministry, NET, Serotonin, Dopamine, Norepinephrine, Safety, MEAI, CWY, Patient, Clinical trial, Yale school, DAT, Psychiatry, Sheba Medical Center, Research, Pharmaceutical industry

Vancouver, Canada, Feb. 23, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq, CSE: CMND), (FSE: CWY) (“Clearmind” or the "company"), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, is pleased to announce it has received approval from the Ministry of Health of Israel to commence its phase I/IIa clinical trial for alcohol use disorder (AUD) patients using the company's proprietary MEAI-based (5-methoxy-2-aminoindane) CMND-100 oral capsule.

Key Points: 
  • "We are thrilled to receive approval to commence our phase I/IIa clinical trial for our lead drug candidate, CMND-100, which has been shown to be safe and effective in preclinical studies.
  • This is the most important milestone for the company to date and marks our transition to a clinical- stage pharmaceutical company.
  • The Clearmind team has been working tirelessly on the research and development of a novel treatment to the global epidemic of alcoholism.
  • We are eager to continue our work with patients in need of help,” said Dr. Adi Zuloff-Shani, CEO of Clearmind Medicine.

Grove Announces Fourth Quarter and Full Year 2023 Financial Results

Retrieved on: 
Wednesday, March 6, 2024
Home Goods, Retail, Specialty, International, PVOH, Partnership, Health, Growth, Alcoholism, The Honest Company, Polyvinyl alcohol, Grove Collaborative, Adjustment, Plastic, Advertising, Webcast, Customer experience, Wellness, Category, Selection, DTC, PVA, Video game

DTC Net Revenue Per Order was $66.83 in the fourth quarter of 2023, another record for Grove, up 2.4% quarter-over-quarter and 5.4% year-over-year.

Key Points: 
  • DTC Net Revenue Per Order was $66.83 in the fourth quarter of 2023, another record for Grove, up 2.4% quarter-over-quarter and 5.4% year-over-year.
  • Plastic Intensity Across the Entire Grove Business - including both Grove Brands and third-party products through online sales and retail partners - was 1.07 pounds of plastic4 per $100 in net revenue in the fourth quarter of 2023, an improvement from 1.11 pounds in the third quarter of 2023 and 1.08 pounds in the fourth quarter of 2022.
  • Plastic Intensity for Grove Brands Only across online and retail sales was 1.07 pounds of plastic per $100 in revenue in the fourth quarter of 2023, an improvement from 1.14 pounds in the third quarter of 2023, but up from 0.98 pounds in the fourth quarter of 2022.
  • Excluding this product category, Grove Brands plastic intensity was 0.57 pounds in the fourth quarter of 2023, an improvement from the third quarter of 2023 of 0.63 pounds but slightly up from 0.56 pounds in the fourth quarter of 2022.